Catheter Precision prices $2.05 million private placement of 2,050 Series C-4 preferred shares
VTAK•Catheter Precision priced a $2.05 million private placement of 2,050 Series C-4 preferred shares, expected to close on or about Oct. 13, 2026. The shares convert at $1.00 each, and the company cut conversion prices on several outstanding preferred series to $1.00 from $2.30.
1. Placement terms
The placement is expected to close on or about Oct. 13, 2026, subject to customary closing conditions. The preferred shares convert at $1.00 per share into up to 2,050,000 common shares, subject to a 4.99% beneficial ownership cap.
2. Conversion price cut
Catheter Precision also cut the conversion price for outstanding Series C-1 through C-4, Series D and Series J preferred stock to $1.00 from $2.30. The securities are unregistered and restricted under Rule 144; the transaction relied on exemptions under Section 4(a)(2) and Rule 506(b).
